A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer

被引：0

作者：

Mohamed S. Zaghloul

Rimoun Boutrus

Hisham El-Hossieny

Yasser Abdel Kader

Inas El-Attar

Mohamed Nazmy

机构：

[1] Cairo University,Radiation Oncology Department, National Cancer Institute

[2] Cairo University,Medical Statistics Department, National Cancer Institute

[3] Children’s Cancer Hospital (CCHE) 57357,Radiation Oncology Department

来源：

International Journal of Clinical Oncology | 2010年 / 15卷

关键词：

Bisphosphonates; Bladder cancer; Bone metastasis; Multiple event analysis; Skeletal-related events; Zoledronic acid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：382 / 389

页数：7

共 50 条

[1] A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
Zaghloul, Mohamed S.
Boutrus, Rimoun
El-Hossieny, Hisham
Kader, Yasser Abdel
El-Attar, Inas
Nazmy, Mohamed
[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 382 - 389
[2] A controlled prospective randomized placebo-controlled trial of Zoledronic acid in bony metastatic bladder cancer patients
Zaghloul, M. S.
Boutrus, R.
El-Hosieny, H.
A-Kader, Y.
El-Attar, I.
Nazmy, M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[3] A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
Saad, F
Gleason, DM
Murray, R
Tchekmedyian, S
Venner, P
Lacombe, L
Chin, JL
Vinholes, JJ
Goas, JA
Chen, B
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (19) : 1458 - 1468
[4] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
Winquist, E
Berry, S
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) : 1183 - 1183
[5] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
Atkins, CD
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04) : 332 - 332
[6] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
Tu, SM
Lin, SH
Logothetis, C
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1174 - 1175
[7] Zoledronic acid effects on pain in patients with prostate cancer and bone metastases in a randomized placebo-controlled trial
Arbuckle, R.
Saad, F.
[J]. CANCER TREATMENT REVIEWS, 2006, 32 : S33 - S33
[8] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma - Response
Saad, F
Gleason, DM
Murray, R
Goas, JA
Chen, B
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (04) : 333 - 334
[9] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma - Response
Saad, F
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) : 1183 - 1184
[10] Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma - Response
Saad, F
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) : 1175 - 1175

← 1 2 3 4 5 →